Results 271 to 280 of about 92,469 (306)
Some of the next articles are maybe not open access.
[On the subject of pancreatic ductal carcinoma].
La Clinica terapeutica, 1999Pancreatic cancer is a dismal disease. The 5-year overall survival ranges from 1% to 5%. Surgery is the only curative treatment available for this cancer, but it is indicated only in selected patients with a less than 4 cm tumor. In these patients, survival rate is about 30%.
D, Pantalone +4 more
openaire +1 more source
Prognostic factors in the operative treatment of ductal pancreatic carcinoma
Langenbeck's Archives of Surgery, 2000The average 5-year survival rate following resection of a ductal adenocarcinoma of the pancreas is 10%, worldwide. Despite increasing resection rates, only about 20% can be operated on with curative intent. A differential histopathological analysis of the resected tumors may help to justify expanding the surgical procedure by extended lymph-node ...
C, Gebhardt +3 more
openaire +2 more sources
[Intraductal intraepithelial neoplasia and ductal pancreatic carcinoma].
Arkhiv patologii, 2006The review of modern achievements in morphology and genetic characteristics of pancreatic tumors with ductal phenotype is presented. Problems of intraductal pancreatic neoplasia (PanIN) as precancerous process for ductal adenocarcinoma are considered in detail.
G A, Galil-Ogly +2 more
openaire +1 more source
Clinical Journal of Gastroenterology, 2011
Recent studies have reported that pancreatic ductal carcinomas are frequently found during the follow-up of pancreatic cysts distinct from carcinoma; however, the majority of them are detected in advanced stages. Therefore, the early detection of metachronous ductal carcinomas is one of the issues in the management of pancreatic cysts.
Natsuko, Kawada +12 more
openaire +2 more sources
Recent studies have reported that pancreatic ductal carcinomas are frequently found during the follow-up of pancreatic cysts distinct from carcinoma; however, the majority of them are detected in advanced stages. Therefore, the early detection of metachronous ductal carcinomas is one of the issues in the management of pancreatic cysts.
Natsuko, Kawada +12 more
openaire +2 more sources
American Journal of Surgical Pathology, 2013
Intraorgan metastasis of a primary cancer within the organ of origin, such as intrahepatic metastasis of hepatocellular carcinoma, is one of the key features for clinicopathologic staging of the cancer. Pancreatic intraglandular metastasis (P-IM) of pancreatic ductal carcinoma (PDC) is encountered occasionally but has not yet been evaluated. The aim of
Seiji, Oguro +8 more
openaire +2 more sources
Intraorgan metastasis of a primary cancer within the organ of origin, such as intrahepatic metastasis of hepatocellular carcinoma, is one of the key features for clinicopathologic staging of the cancer. Pancreatic intraglandular metastasis (P-IM) of pancreatic ductal carcinoma (PDC) is encountered occasionally but has not yet been evaluated. The aim of
Seiji, Oguro +8 more
openaire +2 more sources
Remnant Pancreatectomy for Pancreatic Ductal Carcinoma
HPB, 2022D. Nagashima +6 more
openaire +1 more source
[Neoadjuvant and adjuvant therapy of ductal pancreatic carcinoma].
Zentralblatt fur Chirurgie, 2000The optimal oncological management of ductal pancreatic cancer remains undefined. More than 60% of these patients have disseminated disease at the time of presentation. Here radical surgery alone cannot guarantee a cure. Even in the best case of a R0-resection with extended lymph node dissection the reported 5-year survival rates of 20-30% are ...
W, Hohenberger, S, Kastl
openaire +1 more source
The molecular genetics of pancreatic ductal carcinoma.
Minerva chirurgica, 2003Pancreatic ductal carcinoma remains the 4th leading cause of cancer death in both men and women in the United States, with an overall 5-year survival of less than 3%. Over the last decade, significant advances have been made in our understanding of the molecular biology of pancreatic ductal carcinoma, with pancreatic cancer now considered one of the ...
openaire +1 more source
Proteogenomic characterization of pancreatic ductal adenocarcinoma
Cell, 2021Chen Huang, Daniel Cui Zhou, Yingwei hu
exaly
Pancreatic Ductal Adenocarcinoma: Epidemiology and Risk Factors
Diagnostics, 2021Atsushi Kanno +2 more
exaly